Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Tillmann

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Arthritis Research & Therapy|October 7, 2008
Rationale for prostaglandin I2 in bone marrow oedema--from theory to applicationMarcus Jäger, Frank Peter Tillmann, Thomas S Thornhill, et al.
Journal of Clinical Medicine|June 10, 2022
Effect of Third and Fourth mRNA-Based Booster Vaccinations on SARS-CoV-2 Neutralizing Antibody Titer Formation, Risk Factors for Non-Response, and Outcome after SARS-CoV-2 Omicron Breakthrough Infections in Patients on Chronic Hemodialysis: A Prospective Multicenter Cohort StudyFrank-Peter Tillmann, Lars Figiel, Johannes Ricken, et al.
Clinical Kidney Journal|February 2, 2023
Patiromer utilization in patients with advanced chronic kidney disease under nephrology care in GermanyRoberto Pecoits-Filho, Keith McCullough, Daniel Muenz, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Arthritis Research & Therapy|October 7, 2008
Rationale for prostaglandin I2 in bone marrow oedema--from theory to applicationMarcus Jäger, Frank Peter Tillmann, Thomas S Thornhill, et al.
Journal of Clinical Medicine|June 10, 2022
Effect of Third and Fourth mRNA-Based Booster Vaccinations on SARS-CoV-2 Neutralizing Antibody Titer Formation, Risk Factors for Non-Response, and Outcome after SARS-CoV-2 Omicron Breakthrough Infections in Patients on Chronic Hemodialysis: A Prospective Multicenter Cohort StudyFrank-Peter Tillmann, Lars Figiel, Johannes Ricken, et al.
Clinical Kidney Journal|February 2, 2023
Patiromer utilization in patients with advanced chronic kidney disease under nephrology care in GermanyRoberto Pecoits-Filho, Keith McCullough, Daniel Muenz, et al.
Pageof 3